These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3811789)

  • 1. Turnover study of prothrombin, antithrombin III and fibrinogen in patients with liver cirrhosis.
    Saitoh H; Kobayashi N; Maekawa T
    Nihon Ketsueki Gakkai Zasshi; 1986 Sep; 49(6):1263-74. PubMed ID: 3811789
    [No Abstract]   [Full Text] [Related]  

  • 2. Circadian rhythms of fibrinogen and antithrombin III in liver cirrhosis.
    Pasqualetti P; Casale R
    Riv Eur Sci Med Farmacol; 1995; 17(4):125-9. PubMed ID: 8545565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
    Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
    Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin III versus prothrombin in liver cirrhosis.
    Aurousseau MH; d'Angeli JL; Josso F
    Haemostasis; 1981; 10(2):104-7. PubMed ID: 7461504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albumin, fibrinogen, prothrombin and antithrombin III variations in blood, urines and liver in rat nephrotic syndrome (Heymann nephritis).
    Girot R; Jaubert F; Leon M; Bellon B; Aiach M; Josso F; Lepelletier O; Beguin S; Monnet JP
    Thromb Haemost; 1983 Feb; 49(1):13-7. PubMed ID: 6601862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin III transfusion in patients with hepatic cirrhosis.
    Schipper HG; ten Cate JW
    Br J Haematol; 1982 Sep; 52(1):25-33. PubMed ID: 7115627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen and antithrombin III blood levels fluctuations during isoniazid or isoniazid plus rifampicin administration.
    Farmakis M; Travlou O; Aroni S; Fertakis A
    Arzneimittelforschung; 1992 Aug; 42(8):1041-4. PubMed ID: 1418078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in the values of antithrombin III and other blood coagulation indices in liver cirrhosis without ascites and in the ascitic stage].
    Doncheva N
    Vutr Boles; 1989; 28(4):96-9. PubMed ID: 2596116
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blood coagulation parameters in patients with lichen planus].
    Wankiewicz A; Iwan-Zietek I; Rość D
    Pol Merkur Lekarski; 2004 Jul; 17(97):55-7. PubMed ID: 15559612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The relationship between hemostatic changes in liver cirrhosis patients with different degrees of liver lesions in reference to Child-Pugh scores].
    Cong YL; Wei YX; Zhang LW; Yin ZJ; Bai J
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):31-4. PubMed ID: 15670488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in levels of blood coagulation inhibitors in cirrhosis. Prospective study in 33 patients].
    Dumontier I; Alhenc-Gelas M; Chatellier G; Brenet P; Aiach M; Petite JP
    Gastroenterol Clin Biol; 1992; 16(2):120-5. PubMed ID: 1314744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Platelet aggregation and various coagulation parameters in liver cirrhosis].
    Calabrese S; Giansante C; Sammartini C; Benedetti A
    Minerva Med; 1984 Apr; 75(18):1047-52. PubMed ID: 6728255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemostatic abnormalities in patients with liver disease associated with viral hepatitis.
    Pramoolsinsap C; Busagorn N; Kurathong S
    J Med Assoc Thai; 1996 Nov; 79(11):681-8. PubMed ID: 8997005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on coagulation profile of patients with cirrhosis of the liver undergoing elective fibreoptic injection sclerotherapy of oesophageal varices.
    Bernardi M; Palareti G; Pini P; Caletti GC; Brocchi E; Gasbarrini G
    Hepatogastroenterology; 1984 Jun; 31(3):125-8. PubMed ID: 6469201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis.
    Zhang D; Hao J; Yang N
    J Gastroenterol Hepatol; 2010 Jan; 25(1):116-21. PubMed ID: 19686413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Disorders of coagulation/fibrinolysis and bleeding tendency].
    Endo T; Amemiya N; Kume S
    Nihon Rinsho; 1994 Jan; 52(1):119-23. PubMed ID: 8114280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothrombin activation fragment 1 + 2 and thrombin-antithrombin-III complexes in plasma of patients with essential arterial hypertension.
    Kłoczko J; Wojtukiewicz MZ; Galar M; Tarasów E; Jaromin J; Bielawiec M
    Pol J Pharmacol; 1996; 48(2):233-5. PubMed ID: 9112658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of antithrombin III (AT III) substitution to supranormal activities on systemic procoagulant turnover in patients with end-stage chronic liver disease.
    Scherer R; Kabatnik M; Erhard J; Peters J
    Intensive Care Med; 1997 Nov; 23(11):1150-8. PubMed ID: 9434921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postirradiation changes of plasma coagulation factors and inhibitors of coagulation.
    Klír P; Hlousková D; Pospísil J; Kase F
    Acta Univ Carol Med Monogr; 1987; 119():68-83. PubMed ID: 3324733
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of splenectomy on blood coagulation and fibrinolysis in patients with liver cirrhosis: possible role of the spleen in haemostasis.
    Kamisasa I; Hidai K; Sugiura M; Wada T; Yamanaka M
    Thromb Haemost; 1980 Feb; 42(5):1529-35. PubMed ID: 6989011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.